MINUTI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 309
EU - Europa 147
AS - Asia 86
AF - Africa 9
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 558
Nazione #
US - Stati Uniti d'America 301
DE - Germania 54
CN - Cina 35
SG - Singapore 30
IT - Italia 27
SE - Svezia 21
GB - Regno Unito 14
BG - Bulgaria 13
CA - Canada 7
HK - Hong Kong 6
CH - Svizzera 5
CI - Costa d'Avorio 5
RU - Federazione Russa 5
TR - Turchia 5
VN - Vietnam 5
BR - Brasile 4
IN - India 4
FI - Finlandia 3
AU - Australia 2
FR - Francia 2
NG - Nigeria 2
NL - Olanda 2
AM - Armenia 1
EU - Europa 1
IE - Irlanda 1
LY - Libia 1
MX - Messico 1
SN - Senegal 1
Totale 558
Città #
Fairfield 33
Chandler 32
Houston 32
Ann Arbor 31
Ashburn 26
Santa Clara 24
Singapore 14
Woodbridge 14
Sofia 13
Beijing 12
Shanghai 12
Wilmington 12
Seattle 11
New York 10
London 7
Cambridge 6
Des Moines 6
Hong Kong 6
Princeton 6
Redwood City 6
Abidjan 5
Boardman 5
Bremen 5
Florence 5
Lawrence 5
Ottawa 5
Bologna 4
Dong Ket 4
Lugo 4
Istanbul 3
Medford 3
Nanjing 3
Nürnberg 3
Lagos 2
Lausanne 2
Parma 2
Shenyang 2
Stouffville 2
Américo Brasiliense 1
Botticino 1
Cagliari 1
Changsha 1
Chiswick 1
Council Bluffs 1
Dakar 1
Delhi 1
Dublin 1
Düsseldorf 1
Frankfurt am Main 1
Fuzhou 1
Geneve 1
Grafing 1
Helsinki 1
Itaú de Minas 1
Jiaxing 1
Los Angeles 1
Nuremberg 1
Pelham 1
Phoenix 1
Pisa 1
Quanzhou 1
San Diego 1
Stockholm 1
São Paulo 1
Tlajomulco de Zúñiga 1
Trecate 1
Washington 1
Xiamen 1
Yerevan 1
Totale 408
Nome #
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 178
MicroRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers 125
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial. 109
Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population 93
Italian cohort of nivolumab Expanded Access Programme (EAP): efficacy and safety data from a real-world population 61
Totale 566
Categoria #
all - tutte 1.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.887


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 0 0 13 4
2020/202143 4 2 4 0 7 0 4 0 6 9 2 5
2021/202254 3 1 0 1 13 9 2 2 4 1 3 15
2022/2023108 11 16 9 10 13 16 0 9 14 0 10 0
2023/202430 3 2 4 2 5 9 1 0 0 0 0 4
2024/2025101 0 5 0 9 16 23 10 2 16 16 4 0
Totale 566